Skip to main content
Journal cover image

Twenty-five year evolution of medical hormonal therapy for prostate cancer.

Publication ,  Other
Moul, JW
Published in: BJU Int
January 2009

Duke Scholars

Published In

BJU Int

DOI

EISSN

1464-410X

Publication Date

January 2009

Volume

103

Issue

2

Start / End Page

145 / 146

Location

England

Related Subject Headings

  • Urology & Nephrology
  • Randomized Controlled Trials as Topic
  • Prostatic Neoplasms
  • Prostate-Specific Antigen
  • Oligopeptides
  • Male
  • Leuprolide
  • Humans
  • Gonadotropin-Releasing Hormone
  • Clinical Trials, Phase III as Topic
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Moul, J. W. (2009). Twenty-five year evolution of medical hormonal therapy for prostate cancer. BJU Int. England. https://doi.org/10.1111/j.1464-410X.2008.08271.x
Moul, Judd W. “Twenty-five year evolution of medical hormonal therapy for prostate cancer.BJU Int, January 2009. https://doi.org/10.1111/j.1464-410X.2008.08271.x.
Moul, Judd W. “Twenty-five year evolution of medical hormonal therapy for prostate cancer.BJU Int, vol. 103, no. 2, Jan. 2009, pp. 145–46. Pubmed, doi:10.1111/j.1464-410X.2008.08271.x.
Journal cover image

Published In

BJU Int

DOI

EISSN

1464-410X

Publication Date

January 2009

Volume

103

Issue

2

Start / End Page

145 / 146

Location

England

Related Subject Headings

  • Urology & Nephrology
  • Randomized Controlled Trials as Topic
  • Prostatic Neoplasms
  • Prostate-Specific Antigen
  • Oligopeptides
  • Male
  • Leuprolide
  • Humans
  • Gonadotropin-Releasing Hormone
  • Clinical Trials, Phase III as Topic